Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Series of N-of-1 Randomized Controlled Trials of Ivabradine for Improving Symptom Management in Adolescent Patients With Dysautonomia.

NCT07881302 is registered in ClinicalTrials.gov with Kathryn Armstrong as lead sponsor.

NCT NCT07881302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07881302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Series of N-of-1 Randomized Controlled Trials of Ivabradine for Improving Symptom Management in Adolescent Patients With Dysautonomia.
Lead sponsor
Kathryn Armstrong
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
May 31, 2028
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dysautonomia of adolescence